Milton H. Werner - Net Worth and Insider Trading
Milton H. Werner Net Worth
The estimated net worth of Milton H. Werner is at least $3 Million dollars as of 2024-11-13. Milton H. Werner is the President and CEO, 10% Owner of Inhibikase Therapeutics Inc and owns about 889,241 shares of Inhibikase Therapeutics Inc (IKT) stock worth over $3 Million. Details can be seen in Milton H. Werner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Milton H. Werner has not made any transactions after 2022-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Milton H. Werner
Milton H. Werner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Milton H. Werner owns 1 companies in total, including Inhibikase Therapeutics Inc (IKT) .
Click here to see the complete history of Milton H. Werner’s form 4 insider trades.
Insider Ownership Summary of Milton H. Werner
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IKT | Inhibikase Therapeutics Inc | 2022-08-16 | director & 10 percent owner & President and CEO |
Milton H. Werner Latest Holdings Summary
Milton H. Werner currently owns a total of 1 stock. Milton H. Werner owns 889,241 shares of Inhibikase Therapeutics Inc (IKT) as of August 16, 2022, with a value of $3 Million.
Latest Holdings of Milton H. Werner
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
IKT | Inhibikase Therapeutics Inc | 2022-08-16 | 889,241 | 2.89 | 2,569,906 |
Holding Weightings of Milton H. Werner
Milton H. Werner Form 4 Trading Tracker
According to the SEC Form 4 filings, Milton H. Werner has made a total of 4 transactions in Inhibikase Therapeutics Inc (IKT) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Inhibikase Therapeutics Inc is the acquisition of 833 shares on August 16, 2022, which cost Milton H. Werner around $4,000.
Insider Trading History of Milton H. Werner
- 1
Milton H. Werner Trading Performance
GuruFocus tracks the stock performance after each of Milton H. Werner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Milton H. Werner is -11.16%. GuruFocus also compares Milton H. Werner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Milton H. Werner within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Milton H. Werner's insider trading performs compared to the benchmark.
Performance of Milton H. Werner
Milton H. Werner Ownership Network
Ownership Network List of Milton H. Werner
Ownership Network Relation of Milton H. Werner
Milton H. Werner Owned Company Details
What does Inhibikase Therapeutics Inc do?
Who are the key executives at Inhibikase Therapeutics Inc?
Milton H. Werner is the director & 10 percent owner & President and CEO of Inhibikase Therapeutics Inc. Other key executives at Inhibikase Therapeutics Inc include Cheif Financial Officer Joseph Frattaroli , and 10 percent owner Daniel Kalman .
Inhibikase Therapeutics Inc (IKT) Insider Trades Summary
Over the past 18 months, Milton H. Werner made no insider transaction in Inhibikase Therapeutics Inc (IKT). Other recent insider transactions involving Inhibikase Therapeutics Inc (IKT) include a net purchase of 1,460,000 shares made by , a net purchase of 365,000 shares made by Amit Munshi , and a net purchase of 145,000 shares made by Arvind Kush .
In summary, during the past 3 months, insiders sold 0 shares of Inhibikase Therapeutics Inc (IKT) in total and bought 1,970,000 shares, with a net purchase of 1,970,000 shares. During the past 18 months, 0 shares of Inhibikase Therapeutics Inc (IKT) were sold and 1,970,000 shares were bought by its insiders, resulting in a net purchase of 1,970,000 shares.
Inhibikase Therapeutics Inc (IKT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inhibikase Therapeutics Inc Insider Transactions
Milton H. Werner Mailing Address
Above is the net worth, insider trading, and ownership report for Milton H. Werner. You might contact Milton H. Werner via mailing address: 3350 Riverwood Parkway Se, Suite 1900, Atlanta Ga 30339.